Company: BDRX
Filing Date: 2025-05-12
Form Type: 424B3
Source: 0001214659-25-007342
Chunk: 35

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-12
Form: 424B3
Chunk 35
---
 issued
333,333 units, with each unit comprising one new Ordinary Share and one warrant to purchase one new Ordinary Share, or a UK Warrant. The
exercise price of the UK Warrants are £6.80 per share and they expire five years and six months from the issuance date. We also
issued UK Warrants to purchase a total of 16,400 Ordinary Shares to Turner Pope, the placing agent, in connection with the closing of
such offering, on the same terms and conditions as the other investors in the offering.

| 25 |

August 2022 Warrants

On
August 3, 2022, we issued warrants to purchase 16,400 Ordinary Shares to Strand Hanson Limited, in payment for services rendered. The
exercise price of such warrants is £2.70 per share and they expire three years from the issuance date.

February Placement Agent Warrants

The following is a brief summary
of the February Placement Agent Warrants, and is subject in all respects to the provisions contained in the warrant, which is filed as
an exhibit to our Report on Form 6-K dated February 9, 2023.

Exercisability.
The February Placement Agent Warrants are exercisable and expire three years from the initial exercise date. The holder shall deliver
the aggregate exercise price for the Depositary Shares specified in the exercise notice within two trading days following the date of
exercise (subject to the ‘cashless exercise’ arrangements described below).

Cashless Exercise. The February Placement Agent Warrants may only be exercised on a cashless basis if, following a date that is six months
from the original issuance date, at the time of exercise, there is no effective registration statement registering with a current prospectus
available for resale of the Depositary Shares underlying the February Placement Agent Warrants.

Exercise Price.The exercise price of a portion of the February Placement Agent Warrants are $10,000.00 per Depositary Share and another
portion is $5,800.00 per Depositary Share, respectively, each subject to the ‘cashless exercise’ arrangements described above
and to adjustment as described herein.

Beneficial Ownership Limitation. A holder shall have no right to exercise any portion of a February Placement Agent Warrant, to the extent
that, after giving effect to such exercise, such holder, together with such holder’s affiliates, and any persons acting as a group
together with such holder or any such affiliate, would beneficially own in excess of 4.99